Search Results 1-10 of 16191 for Adenocarcinoma, Non-Small Cell, Lung Cancer, Stage IV

1. Lung cancer - Symptoms and causes - Mayo Clinic

   Non-small cell lung cancer is a category that includes several types of lung cancers. Non-small cell lung cancers include squamous cell carcinoma, ...

2. Lung cancer - Diagnosis and treatment - Mayo Clinic

   As the cancer grows larger or spreads outside of the lungs, the numbers get higher. A stage 4 lung cancer has spread to other areas of the body. In small cell ...

3. Small Cell Lung Cancer Clinical Trials - Mayo Clinic Research

   ... Adenocarcinoma (PDA) Scottsdale/Phoenix, AZ ... stage IV non-squamous non-small cell lung cancer. ... 5 at different dose levels in patients with small cell lung ...

4. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... stage IIIB/IV adenocarcinoma non-small cell lung cancer that has epidermal growth factor receptor (EGFR) activating mutations. This study will also assess ...

5. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients ...

6. Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer - Mayo Clinic

   ... stage IV non-small cell lung cancer. Drugs used ... carcinoma of breast, oral cavity, skin, or cervix ... not eligible for this study; Patients with ...

7. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... Stage IV Non-Small Cell Lung Cancer. Print details. Share; Facebook · Twitter ... adenocarcinoma, squamous cell carcinoma, large cell carcinoma, undifferentiated ...

8. A Study to Evaluate Biomarker/ALK Inhibitor Combinations in Treating Patients With Stage IV ALK Positive Non-squamous Non-small Cell Lung Cancer (The NCI-NRG ALK Protocol) - Mayo Clinic

   ... stage IV ALK positive non-squamous non-small cell lung cancer. Lorlatinib, ceritinib, alectinib, brigatinib, ensartinib, and crizotinib may stop the growth ...

9. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   ... (Stage IV) Non-small Cell Lung Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

10. Erlotinib with or without Bevacizumab in Treating Patients with Stage IV Non-Small Cell Lung Cancer with EGFR Mutations - Mayo Clinic

    ... Stage IV Non-Small Cell Lung Cancer with EGFR Mutations ... lung carcinoma, non ... Mixed, non-small cell and small cell tumors or mixed adenosquamous carcinomas ...